|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
QUIZARTINIB |
L01EX11 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
ETRASIMOD |
L04AE05 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
LAZERTINIB |
L01EB09 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006074 |
20-01-2025 |
VALID
|
|
IMETELSTAT |
L01XX80 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
GARADACIMAB |
B06AC07 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006116 |
10-02-2025 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
NEMOLIZUMAB |
D11AH12 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006149 |
12-02-2025 |
VALID
|
|
SERPLULIMAB |
L01FF12 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006170 |
03-02-2025 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
MARSTACIMAB |
B02BX11 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
SIPAVIBART |
J06BD09 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006291 |
20-01-2025 |
VALID
|
|
EPLONTERSEN |
N07XX21 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006295 |
06-03-2025 |
VALID
|
|
ACORAMIDIS |
C01EB25 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006333 |
10-02-2025 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
ROSUVASTATIN |
C10AA07 |
RO
|
List II
|
04-12-2024 |
RO/H/0105/002/II/005 |
03-06-2013 |
VALID
|
|
BICALUTAMIDE |
L02BB03 |
RO
|
List I
|
|
RO/H/0114/001/ |
01-06-2012 |
VALID
|
|
CLOPIDOGREL |
B01AC04 |
RO
|
List I
|
|
RO/H/0120/001/ |
01-10-2014 |
VALID
|
|
CAPECITABINE |
L01BC06 |
RO
|
List I
|
|
RO/H/0121/002/ |
08-03-2013 |
VALID
|
|
EXEMESTANE |
L02BG06 |
RO
|
List I
|
|
RO/H/0126/001/ |
11-07-2014 |
VALID
|
|
ACLIDINIUM BROMIDE |
R03BB05 |
RO
|
List I
|
|
None |
|
VALID
|
|
ADALIMUMAB |
L04AB04 |
RO
|
List I
|
|
None |
|
VALID
|
|
ADEFOVIR DIPIVOXIL |
J05AF08 |
RO
|
List I
|
|
None |
|
VALID
|
|
AFATINIB |
L01EB03 |
RO
|
List I
|
|
None |
|
VALID
|
|
AFLIBERCEPT |
S01LA05 |
RO
|
List I
|
|
None |
|
VALID
|
|
AGOMELATINE |
N06AX22 |
RO
|
List I
|
|
None |
|
VALID
|
|
ALEMTUZUMAB |
L04AG06 |
RO
|
List I
|
|
None |
|
VALID
|
|
ALENDRONIC ACID AND COLECALCIFEROL |
M05BB03 |
RO
|
List II
|
|
None |
|
VALID
|
|
ALGLUCOSIDASE ALFA |
A16AB07 |
RO
|
List I
|
|
None |
|
VALID
|
|
ALISKIREN |
C09XA02 |
RO
|
List I
|
|
None |
|
VALID
|
|
ALISKIREN AND HYDROCHLOROTHIAZIDE |
C09XA52 |
RO
|
List I
|
|
None |
|
VALID
|
|
ALOGLIPTIN |
A10BH04 |
RO
|
List I
|
|
None |
|
VALID
|
|
AMBRISENTAN |
C02KX02 |
RO
|
List I
|
|
None |
|
VALID
|
|
ANAGRELIDE |
L01XX35 |
RO
|
List I
|
|
None |
|
VALID
|
|
ANAKINRA |
L04AC03 |
RO
|
List I
|
|
None |
|
VALID
|
|
ANIDULAFUNGIN |
J02AX06 |
RO
|
List I
|
|
None |
|
VALID
|
|
ANTITHROMBIN III |
B01AB02 |
RO
|
List I
|
|
None |
|
VALID
|
|
ARIPIPRAZOLE |
N05AX12 |
RO
|
List I
|
|
None |
|
VALID
|
|
ARSENIC TRIOXIDE |
L01XX27 |
RO
|
List I
|
|
None |
|
VALID
|
|
ARTENIMOL AND PIPERAQUINE |
P01BF05 |
RO
|
List I
|
|
None |
|
VALID
|
|
ASENAPINE |
N05AH05 |
RO
|
List I
|
|
None |
|
VALID
|
|
ATOSIBAN |
G02CX01 |
RO
|
List I
|
|
None |
|
VALID
|
|
BARBITURATES IN COMBINATION WITH OTHER DRUGS |
N05CB02 |
RO
|
List II
|
|
None |
|
VALID
|
|
BAZEDOXIFENE |
G03XC02 |
RO
|
List I
|
|
None |
|
VALID
|
|
BECAPLERMIN |
D03AX06 |
RO
|
List I
|
23-02-2017 |
None |
|
VALID
|
